Interview with Vicki St Quintin, COO, PIASA. Pharmaceutical Industry Association…
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day by half – but…
Address: Thornhill Office Park, Building No 5, 94 Bekker Street
Vorna Valley 1686, South Africa ,South Africa
Tel: +27 11 805 51 00
Web: http://www.piasa.co.za/default.asp
The Pharmaceutical Industry Association of South Africa (PIASA) is a trade association of companies involved in the manufacture and/or marketing of prescription medicines in South Africa.
Membership is voluntary and includes a broad representation of foreign multinational pharmaceutical companies and local companies, both large and small. PIASA currently represents approximately 33% of the total private sector pharmaceutical market in South Africa.
The members of PIASA aim to bring the best medicines to the South African market. PIASA companies are important members of the South African business community, marketing medicines, including both innovative and generic medicines, to the health professions. In addition to promoting and safeguarding the interests of members PIASA provides a service to the public as well as the general medical and healthcare community.
Mission
To sustain a favourable environment for the continued development of the pharmaceutical industry in South Africa as it strives to increase access to quality medicines, with the ultimate aim of saving lives and improving the quality of life for all South Africans
Values
Members of PIASA subscribe to the following values:
Respect for intellectual property rights
Commitment to good corporate governance
Commitment to the Code of Marketing Practice
Adherence to best practice in manufacturing, clinical research, distribution and regulatory affairs.
Profile
Pharmaceutical trade organisation – voluntary membership.
Members comprise research based multinational, local/generic and empowerment pharmaceutical companies operating in SA.
18 members
32% Private Sector Market Share
Represents South Africa internationally as a member of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
association
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day by half – but…
The owner of Altis Biologics, Nick Duneas, illustrates the significance of the company’s flagship product, the Altis Osteogenic Bone Matrix (OBM) and how the company plans to commercialize the injectable bone…
The managing director of Trinity Pharma, Gaby Simaan (Jnr) depicts Trinity’s evolution from a regulatory consultancy into a fully commercialized pharmaceutical company, and how their unique position in the private…
The managing director of Galderma South Africa, Jenny Wright reveals the importance of the dermatology sector within the country’s healthcare system, as well as the role Galderma is playing in…
The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health…
The Head of the Department of Medicine at the Faculty of Health Science at the University of Cape Town reveals how their role is not only in training people to…
The managing director of Adcock Ingram’s prescription business, Ashley Pearce highlights the division’s strategic placement within the group’s overall activities, and how he plans on leveraging partnerships with various multinationals,…
The general manager of Ferring South Africa, Mercia Van Zyl discusses the company’s ambitious plans for the future under the slogan ‘People come first’, the placement of fertility under the…
The CEO of IPASA reveals how over the last ten months the priority has been to reach out to different stakeholders, rebuilding trust with the department of health, with patients…
The director of MRA Regulatory Consultants, Henriette Vienings reveals the important role they play in helping pharmaceutical companies navigate South Africa’s regulatory environment, as well as the importance of the…
The country president for South Africa & Sub-Saharan Africa at AstraZeneca reveals why AstraZeneca sees Africa as the next frontier within the pharmaceutical industry, how their Research Trust looks to…
The head of pharma for Bayer Southern Africa reveals how South Africa plays a key role in Bayer’s African strategy, with more than 60 percent of the continent’s total sales,…
The CEO of Pharma Dynamics explains why the company was the perfect match for Lupin, as the fastest growing, and largest independently owned acquirable pharmaceutical business in South Africa, why…
See our Cookie Privacy Policy Here
